P-003
HER2‑Positive Breast Cancer
Phase 3Active
Key Facts
About Panacea Biotec
India‑based pharma delivering generics, biosimilars, and novel oncology drugs with a strong formulation platform.
View full company profileTherapeutic Areas
Other HER2‑Positive Breast Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| Herceptin (Trastuzumab) Biosimilar | NeuClone | Phase 1 |
| Perjeta (Pertuzumab) Biosimilar | NeuClone | Process Scale‑up |
| MagSense™ HER2 Imaging Agent | Imagion Biosystems | Phase 2 |
| Trastuzumab Biosimilar | Hetero | Phase 3 |
| Legrand‑Herceptin Biosimilar | Laboratorios Legrand | Commercial |
| AfriMab-1 | Afrigen Biologics | Preclinical |
| Biosimilar Trastuzumab | Biosidus | Commercial |
| Trazher | Innogene Kalbiotech | Commercial |
| MINC‑trastuzumab | Suntec Medical | Preclinical |